Abstract:AIM To compare the inhibitive effect on gastric acid after a single dose of rabeprazole 10,20 mg, esomeprazole 20,40 mg in healthy H. pylori (Hp)-negative subjects. METHODS This was a randomized, multi-center,open-label, single-dose, four-way crossover study. Each subject received a single dose of rabeprazole 10 mg and 20 mg, esomeprazole 20 mg and 40 mg, respectively. 24-h intragastric pH was monitored simultaneously. There were 14 d washout time before taking the medication. Parameters included basic pH, the onset time of pH ＞ 4 after the medication, daytime recording time (09:00-22:00) and nighttime recording time(22:00-8:00), the median value and the time spent of pH ＞ 4 in daytime recording and night time recording, acid breakthrough time (pH ＜ 4) during the night time. RESULTS There were no difference of the median values of intragastric pH before and after drug administration. Both rabeprazole and esomeprazole in different single dosages can take inhibitive effect in 3 h. The onset time of rabeprazole in 10 mg and 20 mg was significantly faster than that of esomeprazole in 20 mg and 40 mg( P ＜ 0.05) respectively. Except the median value of rabeprazole 20 mg and esomeprazole 40 mg was longer than that in esomeprazole 20 mg, there was no significant difference of intragastric pH ＞ 4 in any other dosage. There was no significant difference of the time spent of pH ＞ 4 in daytime among all drug administrations of rabeprazole and esomeprazole. However, the time spent of pH ＞ 4 in nighttime of rabeprazole 20 mg was significantly longer than that of esomeprazole 20 mg( P ＜ 0.01) and 40 mg( P ＜ 0.05). It was found that the time spent of pH ＞ 4 in nighttime of rabeprazole 10 mg was significantly longer than that of esomeprazole 20 mg ( P ＜ 0.01 ).The nocturnal acid breakthrough (NAB) time of rabeprazole 20 mg was significantly shorter than that of esomeprazole 20 mg ( P ＜ 0.01) and 40 mg( P ＜ 0.05). The acid breakthrough time during the nighttime in rabeprazole 10 mg and esomeprazole 40 mg was significantly shorter than that in esomeprazole 20 mg( P ＜ 0.05). But there were no significant differences among other drug administrations. CONCLUSION Single dose rabeprazole in 10 mg and 20 mg and esomeprazole in 20 mg and 40 mg both can effectively inhibit gastric acid in Hp negative healthy volunteers. However, the rabeprazole takes effect more quickly and has stronger acid inhibitive effect at nighttime in comparion with esomeprazole, rabeprazole is more appropriate in controlling NAB.

<TITLE>COMPARATIVE EFFECTS OF ESOMEPRAZOLE AND OMEPRAZOLE IN TREATING REFLUX ESOPHAGITIS OF THE AGED

Comparison on relief of symptoms and acid suppression of Rabeprazole and Omeprazole on reflux esophagitis in aged

Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.

Clinical efficacy of omeprazole combined mosapride in treating reflux esophagitis

Effect of Omeprazole in treating peptic ulcers of children

Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis

Effect of Esomeprazole and Rabeprazole on Intragastric Ph in Healthy Chinese: an Open, Randomized Crossover Trial

Quality of Life and Cost-Effectiveness of Combined Therapy for Reflux Esophagitis.

Risk factors for sanitary condemnation in broiler chickens and their relative impact: application of an original multiblock approach

Acid-suppressive effects of generic omeprazole: comparison of three brands of generic omeprazole with original omeprazole.

Efficacy and Safety of Omeprazole for the Treatment of Acid Peptic Disorders: A Systematic Review and Meta-Analysis

Comparison of the inhibitive effect on gastric acid between single dose rabeprazole and esomeprazole in healthy volunteers

Clinicai Investigation on Esomeprazoie Treatment of Sixty-Nine Asthmatic Patients with Gastroesophageal Reflux Symptoms

An analysis of 1119 cases with reflux esophagitis in the elderly

Symptom relief in patients with reflux esophagitis: Comparative study of omeprazole, lansoprazole, and rabeprazole

Clinical Characteristics of Gastroesophageal Reflux Disease in the Aged Patients

Acid-suppressive Effects of Rabeprazole: Comparing 10mg and 20mg Twice Daily in Japanese Helicobacter Pylori-Negative and -Positive CYP2C19 Extensive Metabolisers

Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment

The Efficacy of Esomeprazole in Preventing Stress Ulcer in the Mechanical Ventilation Patients

Clinical observation and esophageal dynamical analysis of esomeprazole combined with itopride in the treatment of gastroesophageal relfux disease

Vonoprazan 10 mg or 20 mg vs. lansoprazole 15 mg as maintenance therapy in Asian patients with healed erosive esophagitis: A randomized controlled trial